Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for ...
BofA analyst Tim Anderson raised the firm’s price target on Eli Lilly (LLY) to $1,000 from $997 and keeps a Buy rating on the shares after ...
As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
In a report released yesterday, Mark Lipacis from Evercore ISI maintained a Hold rating on Qualcomm (QCOM – Research Report), with a price ...
The Dow Jones Industrial Average ( ^DJI) fell 0.3%. Meanwhile, the S&P 500 ( ^GSPC) rose more than 0.3% while the tech-heavy ...
Stock market today: Wall Street drifts as Ford and Qualcomm offset rising fashion and tobacco stocks
Wall Street is drifting as drops for Ford Motor and Qualcomm work against buoyant fashion and cigarette stocks. The S&P 500 ...
Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...
Investing.com--US stocks edged higher Thursday, as investors assessed a deluge of corporate earnings as well as more labor market data. At 09:45 ET (14:45 GMT), the Dow Jones Industrial Average rose ...
U.S. stock futures are edging mostly higher as market participants focus on tech stocks and corporate earnings; Honeywell ...
Failed to fetch dynamically imported module: https://au.finance.yahoo.com/assets/_app/immutable/nodes/19.CVin4ONc.js ...
Don't swing for the fences even as the stock market scales worries, says Citi. Here's its barbell portfolio. Investors should take a more prudent approach during a volatile first half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback